Autor: "Gordon Sussman" - OpacWWW

Tytuł:: Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy.
Autorzy:: Langlois A; 1Department of Allergy and Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC Canada.
Lavergne MH; Centre Hospitalier Sainte-Justine Research Center, Montreal, QC Canada.
Leroux H; Centre Hospitalier Sainte-Justine Research Center, Montreal, QC Canada.
Killer K; Centre Hospitalier Sainte-Justine Research Center, Montreal, QC Canada.
Azzano P; 1Department of Allergy and Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC Canada.
Paradis L; 1Department of Allergy and Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC Canada.; 3Department of Allergy and Immunology, Centre Hospitalier de l'Université de Montréal, 3175 Chemin de la Côte Sainte-Catherine, Montreal, QC H3T1C5 Canada.
Samaan K; 1Department of Allergy and Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC Canada.
Lacombe-Barrios J; 1Department of Allergy and Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC Canada.
Eiwegger T; 4Division of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children, The University of Toronto, Toronto, ON Canada.
Upton J; 4Division of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children, The University of Toronto, Toronto, ON Canada.
Sussman G; Gordon Sussman Clinical Research, Toronto, ON Canada.
Poder T; 6Department of Management, Evaluation and Health Policy, School of Public Health, Université de Montréal, Montreal, QC Canada.; 7Research Center of the Institut Universitaire de Santé Mentale de Montréal, Montreal, QC Canada.
Mâsse B; Centre Hospitalier Sainte-Justine Research Center, Montreal, QC Canada.; 8School of Public Health, Université de Montréal, Montreal, QC Canada.
Roches AD; 1Department of Allergy and Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC Canada.; Centre Hospitalier Sainte-Justine Research Center, Montreal, QC Canada.
Bégin P; 1Department of Allergy and Immunology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC Canada.; Centre Hospitalier Sainte-Justine Research Center, Montreal, QC Canada.; 3Department of Allergy and Immunology, Centre Hospitalier de l'Université de Montréal, 3175 Chemin de la Côte Sainte-Catherine, Montreal, QC H3T1C5 Canada.; Pokaż więcej
Źródło:: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2020 May 20; Vol. 16, pp. 38. Date of Electronic Publication: 2020 May 20 (Print Publication: 2020).
Typ publikacji:: Published Erratum

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: CSACI position statement: Newer generation H 1 -antihistamines are safer than first-generation H 1 -antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria.
Autorzy:: Fein MN; 1Division of Clinical Immunology and Allergy, McGill University, Montreal, QC Canada.
Fischer DA; 2Division of Allergy and Clinical Immunology, Western University, London, ON Canada.; 3The Canadian Society of Allergy and Clinical Immunology, Ottawa, ON Canada.
O'Keefe AW; 4Division of Pediatrics, Faculty of Medicine, Memorial University, St. John's, NL Canada.
Sussman GL; Gordon Sussman Clinical Research, Toronto, ON Canada.; Pokaż więcej
Źródło:: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology [Allergy Asthma Clin Immunol] 2019 Oct 01; Vol. 15, pp. 61. Date of Electronic Publication: 2019 Oct 01 (Print Publication: 2019).
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.
Autorzy:: Weller K; Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
Maurer M; Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
Grattan C; Dermatology Centre, Norfolk and Norwich University Hospital, Norwich, UK.
Nakonechna A; Allergy and Immunology Clinic, Royal Liverpool and Broadgreen University Hospital, Liverpool, UK.
Abuzakouk M; Allergy and Immunology Clinic, Royal Liverpool and Broadgreen University Hospital, Liverpool, UK.
Bérard F; Clinical Immunology and Allergology, CH Lyon-Sud, Claude Bernard University Lyon I - Faculty of Medicine, Lyon Sud, Lyon, France.
Sussman G; Gordon Sussman Clinical Research Inc. 202 St Clair Avenue West, Toronto, Canada.
Giménez-Arnau AM; Dermatology Department, Hospital del Mar, Institut Mar d'Investigacions Mèdiques, Universitat Autònoma, Barcelona, Spain.
Ortiz de Frutos J; Hospital Universitario 12 de Octoubre, Dermatology Department, Madrid, Spain.
Knulst A; Department of Dermatology and Allergy, UMC, Utrecht, The Netherlands.
Canonica GW; University of Genoa, San Martino-IST, Genoa, Italy.
Hollis K; RTI Health Solutions, Raleigh, NC USA.
McBride D; RTI Health Solutions, Manchester, UK.
Balp MM; Novartis Pharma AG, Basel, Switzerland.; Pokaż więcej
Źródło:: Clinical and translational allergy [Clin Transl Allergy] 2015 Aug 17; Vol. 5, pp. 29. Date of Electronic Publication: 2015 Aug 17 (Print Publication: 2015).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Gordon Sussman"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja